Cargando…

Arachidonic acid is associated with dyslipidemia and cholesterol-related lipoprotein metabolism signatures

INTRODUCTION: Abnormal lipoprotein metabolism is associated with a variety of diseases, cardiovascular disease in particular. Free fatty acids (FAs) and triglycerides (TGs) are the principal lipid species in adipocytes and are the major components of lipoproteins. However, in routine clinical labora...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Fan, Wang, Yu, Yu, Huahui, Gao, Xiaoqian, Li, Linyi, Sun, Haili, Qin, Yanwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760855/ https://www.ncbi.nlm.nih.gov/pubmed/36545018 http://dx.doi.org/10.3389/fcvm.2022.1075421

Ejemplares similares

Transcriptome data analysis of primary cardiomyopathies reveals perturbations in arachidonic acid metabolism
por: Chauhan, Pankaj Kumar, et al.
Publicado: (2023)

The interaction between uric acid and high-density lipoprotein cholesterol on the prognosis of patients with acute myocardial infarction
por: Yang, Yu, et al.
Publicado: (2023)

Association of the Monocyte–to–High-Density Lipoprotein Cholesterol Ratio With Diabetic Retinopathy
por: Tang, Xixiang, et al.
Publicado: (2021)

Achieved low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio predicts the pathophysiological evolution of lipid-rich plaques in acute coronary syndromes: an optical coherence tomography study
por: He, Luping, et al.
Publicado: (2023)

Angiopoietin-Like Protein 4 May Be an Interplay Between Serum Uric Acid and Triglyceride-Rich Lipoprotein Cholesterol
por: Peng, Yani, et al.
Publicado: (2022)

Global Burden Attributable to High Low-Density Lipoprotein-Cholesterol From 1990 to 2019
por: Du, Heyue, et al.
Publicado: (2022)

Cholesterol efflux capacity is associated with lipoprotein size and vascular health in mild to moderate psoriasis
por: Berg, Alexander R., et al.
Publicado: (2023)

Comprehensive Metabolomics and Machine Learning Identify Profound Oxidative Stress and Inflammation Signatures in Hypertensive Patients with Obstructive Sleep Apnea
por: Du, Zhiyong, et al.
Publicado: (2022)

Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies
por: Jin, Xiao, et al.
Publicado: (2022)

Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
por: Bardolia, Chandni, et al.
Publicado: (2021)

Impact of low-density lipoprotein cholesterol on progression of aortic valve sclerosis and stenosis
por: Seo, Jeong Hun, et al.
Publicado: (2023)

Low-Density Lipoprotein Cholesterol 4: The Notable Risk Factor of Coronary Artery Disease Development
por: Wu, Dongmei, et al.
Publicado: (2021)

Impact of low-density lipoprotein cholesterol and lipoprotein(a) on mid-term clinical outcomes following coronary artery bypass grafting: A secondary analysis of the DACAB trial
por: Yu, Qixiang, et al.
Publicado: (2023)

Comparison of a Machine Learning Method and Various Equations for Estimating Low-Density Lipoprotein Cholesterol in Korean Populations
por: Kwon, Yu-Jin, et al.
Publicado: (2022)

Trajectory of low-density lipoprotein cholesterol in patients with chronic kidney disease and its association with cardiovascular disease
por: Wang, Shih-Wei, et al.
Publicado: (2022)

The U-shaped association of non-high-density lipoprotein cholesterol with all-cause and cardiovascular mortality in general adult population
por: Huang, Yu, et al.
Publicado: (2023)

Baseline Low-Density-Lipoprotein Cholesterol Modifies the Risk of All-Cause Death Associated With Elevated Lipoprotein(a) in Coronary Artery Disease Patients
por: Yao, Younan, et al.
Publicado: (2022)

Prognostic Role of Neutrophil to High-Density Lipoprotein Cholesterol Ratio for All-Cause and Cardiovascular Mortality in the General Population
por: Jiang, Ming, et al.
Publicado: (2022)

The U-Shaped Association of Non-High-Density Lipoprotein Cholesterol Levels With All-Cause and Cardiovascular Mortality Among Patients With Hypertension
por: Cheng, Qi, et al.
Publicado: (2021)

Comparison of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement and Lipid-Lowering Therapy in the Patients With Coronary Artery Disease With Different Renal Functions
por: Zhang, Shuang, et al.
Publicado: (2022)

Endothelial Lipase Is Involved in Cold-Induced High-Density Lipoprotein Turnover and Reverse Cholesterol Transport in Mice
por: Schaltenberg, Nicola, et al.
Publicado: (2021)

Predictive value of atherogenic index of plasma and atherogenic index of plasma combined with low-density lipoprotein cholesterol for the risk of acute myocardial infarction
por: Chen, Min, et al.
Publicado: (2023)

U-Shaped Relationship of Low-Density Lipoprotein Cholesterol With Risk of Severe COVID-19 From a Multicenter Pooled Analysis
por: Gong, Jiao, et al.
Publicado: (2021)

S100/RAGE-Mediated Inflammation and Modified Cholesterol Lipoproteins as Mediators of Osteoblastic Differentiation of Vascular Smooth Muscle Cells
por: Chellan, Bijoy, et al.
Publicado: (2018)

Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review
por: Ravnskov, Uffe, et al.
Publicado: (2016)

Relationship between high-density lipoprotein cholesterol levels and endothelial function in women: a cross-sectional study
por: Takaeko, Yuji, et al.
Publicado: (2020)

Lipoprotein-Induced Increases in Cholesterol and 7-Ketocholesterol Result in Opposite Molecular-Scale Biophysical Effects on Membrane Structure
por: Ayee, Manuela A.A., et al.
Publicado: (2021)

CYP2C19 metabolizer phenotypes may affect the efficacy of statins on lowering small dense low-density lipoprotein cholesterol of patients with coronary artery disease
por: Dai, Ruozhu, et al.
Publicado: (2022)

Effect of Low-Density Lipoprotein Cholesterol Goal Achievement on Vascular Physiology Evaluated by Quantitative Flow Ratio in Patients Who Underwent Percutaneous Coronary Intervention
por: Chen, Long, et al.
Publicado: (2021)

Autotaxin and Lipoprotein Metabolism in Calcific Aortic Valve Disease
por: Mathieu, Patrick, et al.
Publicado: (2019)

High Density Lipoproteins: Metabolism, Function, and Therapeutic Potential
por: Jomard, Anne, et al.
Publicado: (2020)

The Arachidonic Acid Metabolome Serves as a Conserved Regulator of Cholesterol Metabolism
por: Demetz, Egon, et al.
Publicado: (2014)

Changes in Impaired Fasting Glucose and Borderline High Low-Density Lipoprotein-Cholesterol Status Alter the Risk of Cardiovascular Disease: A 9-Year Prospective Cohort Study
por: Wang, Xianxuan, et al.
Publicado: (2022)

Association between low-density lipoprotein cholesterol level and mortality in patients with cardiogenic shock: a retrospective cohort study
por: Jin, Jiali, et al.
Publicado: (2021)

Achievement of low-density lipoprotein cholesterol targets in Chinese patients with atherosclerotic cardiovascular disease after receiving statins and ezetimibe
por: Cheng, Yinchu, et al.
Publicado: (2022)

Low-density lipoprotein-cholesterol lowering effect of a nutraceutical regimen with or without ezetimibe in hypercholesterolaemic patients with statin intolerance
por: Ward, Natalie C., et al.
Publicado: (2022)

Association between extremely high-density lipoprotein cholesterol and adverse cardiovascular outcomes: a systematic review and meta-analysis
por: Zhang, Guanwei, et al.
Publicado: (2023)

Prevalence, Pattern and Predictors for Dyslipidemia of Chinese Women With Polycystic Ovary Syndrome
por: Luo, Xi, et al.
Publicado: (2021)

Etiology and Management of Dyslipidemia in Patients With Cancer
por: de Jesus, Mikhail, et al.
Publicado: (2022)

Predictive Value of Non-high-Density Lipoprotein Cholesterol and Neutrophil-Lymphocyte Ratio for Coronary Artery Vulnerable Plaques in Type 2 Diabetes Mellitus
por: Huang, Xiyi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8fu07f172l5tjd818b5djlpb6n